Latest in News & Research
Rituximab + Prednisone Yields Lasting Complete Remission in Pemphigus
Relapses occurred in 42.2 and 83.7 percent of patients receiving rituximab plus prednisone versus prednisone alone
Most Melanomas in Black Patients Located on Acral Skin
Patients with nonacral cutaneous melanomas more likely to be immunocompromised, have personal history of cancer
Climatic Hazards Linked to Aggravation of Atopic Dermatitis
Evidence of aggravation of AD seen for most climatic hazards, with impact ranging from direct to indirect effects
Study IDs Risks to Offspring Associated With Prenatal Opioid Exposure
Prenatal opioid exposure linked to increased risk for infection, eczema and dermatitis, and asthma in offspring
FDA Approves AI Device That Helps Spot Skin Cancer
The first medical device powered by artificial intelligence and designed to help doctors catch skin cancer has been approved by the U.S. Food and...
Factors ID'd That Affect Medical Decision-Making in Hidradenitis Suppurativa
Five factors identified, including suffering threshold, perceptions of treatment risk, treatment fatigue
What Are the Skin Cancer Recurrence Rates for Superficial X-Ray Therapy?
Over 22 years, two-, five-, and 10-year tumor recurrence rates were 2.2, 6.0, and 10.5 percent, respectively
Is Dermoscopy, Reflectance Confocal Microscopy Combo Best for Assessing Vitiligo?
Sensitivity and specificity of dermoscopy combined with RCM was higher than RCM or dermoscopy alone
12.8 Percent of Unique Prescribers Prescribed Topical Antifungals in 2021
Top 10 percent of prescribers by volume prescribed 44.2 percent of all prescriptions for antifungals
Some Advanced Melanoma Patients Start Systemic Therapy Shortly Before Death
Reduced odds of receiving immune therapy seen in association with female sex, elevated LDH, BRAF mutation, poor ECOG performance status
Does COVID-19 Infection Raise the Odds of Alopecia Areata?
Patients with COVID-19 have a significantly higher incidence of AA than controls, irrespective of clinical subtype
LAUNCH ALERT: Berdazimer Topical Gel 10.3% (ZELSUVMI) Receives FDA Approval for Treatment of Molluscum Contagiosum in Adult and Pediatric Patients
The groundbreaking treatment is the first-and-only topical prescription medication for molluscum that can be applied outside of a medical setting
Transgender, Gender-Diverse Individuals Report Acne-Related Stigma
Barriers to acne treatment include cost, lack of multidisciplinary care, mistrust toward health care system
Does Adapalene/Benzoyl Peroxide Gel Prevent Scar Worsening in Acne?
Maintenance therapy with adapalene/benzoyl peroxide gel and benzoyl peroxide gel effective in acne vulgaris
Variants in Cancer-Predisposing Genes Linked to Early-Onset Merkel Cell Carcinoma
19 percent of patients with early-onset Merkel cell carcinoma have well-described variants in genes associated with cancer predisposition
Skin Clinic Visits Increased With High Carbon Monoxide Levels Due to Wildfires
Atypical summer peak CO levels in Boston region in 2023 linked to spike in AD, dermatitis, eczema-related clinic visits
Biological Agent Trials for Psoriasis Rarely Include Patient Images
A total of 203 images were shared depicting 60 patients, for an overall sharing rate of 0.1 percent
Updated Guidelines Released for Management of Atopic Dermatitis
Changes in this update include guidance on shared decision-making, factors to consider for each recommendation
Is Deucravacitinib Better Than Placebo, Apremilast for Scalp Psoriasis?
Deucravacitinib more efficacious for improving moderate-to-severe scalp psoriasis, and is well tolerated
Study Looks at Incidence of Melanoma Among Indigenous Americans
Incidence rates higher among men than women and for those aged 55 years or older versus age 15 to 39 years
One in Five New Dermatology Drugs Were First in Class Over the Past Decade
Furthermore, nearly four in 10 new dermatologic drug approvals were deemed clinically useful
Launch Alert: Adbry Approval for Pediatric AD
Expanded approval for pediatric patients alters the landscape for moderate-to-severe atopic dermatitis care
Risk for Vitiligo Increased for Transplant Recipients
Increased risk seen for those receiving allogeneic grafts and autologous grafts, as well as those with and without comorbid GVHD
24 of 1292